{
    "Participant": "hu241DEA", 
    "Report URL": "http://evidence.personalgenomes.org/genomes?display_genome_id=aaf5b2288392e8774ec19379170086237e460f29", 
    "Variants": [
        {
            "Allele Frequency": "0.14", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "45411941", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "High", 
            "Condition Tags": [
                "Mental and behavioral", 
                "Nervous system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "APOE", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "9343467", 
                "11950276", 
                "15123497", 
                "17428983"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": "3", 
                "Penetrance": "4", 
                "Severity": "4", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is generally known as the ApoE4 allele of ApoE and is associated with increased risk of Alzheimer's. 20-25% of individuals are heterozygous for this variant, and 1-2% are homozygous. Data from Khachaturian et al. suggests an average 7% of all individuals developed Alzheimer's by the age of 80; when this is split by ApoE4 status: 10% of ApoE4 heterozygotes (3% increased attributable risk), 40% of ApoE4 homozygotes (33% increased attributable risk), and 5% of non-carriers (2% decreased attributable risk). Notably, their model suggests 70-75% of people would eventually develop Alzheimer's by the age of 100 regardless of ApoE4 genotype (and 25-30% are resistant, regardless of genotype), but that ApoE4 variants shift the disease onset to occur significantly earlier (4 years earlier for heterozygous carriers, 13 years for homozygotes).", 
            "URL": "http://evidence.pgp-hms.org/APOE-C130R", 
            "Variant Name": "APOE-C130R", 
            "Variant Page": "http://evidence.pgp-hms.org/APOE-C130R", 
            "dbSNP IDs": [
                "rs429358"
            ]
        }, 
        {
            "Allele Frequency": "0.041", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "68174189", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "High", 
            "Condition Tags": [
                "Hearing and vision", 
                "Muscular, skeletal, and connective tissue"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "LRP5", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "11719191"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": "5", 
                "Severity": "4", 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant has been implicated in causing osteoporosis-pseudoglioma syndrome in a recessive manner. The gene is strongly implicated in causing the disease, but an insufficient number of controls means this variant's observation lacks statistical significance. The condition manifests in childhood with early onset osteoporosis and eye problems.", 
            "URL": "http://evidence.pgp-hms.org/LRP5-V667M", 
            "Variant Name": "LRP5-V667M", 
            "Variant Page": "http://evidence.pgp-hms.org/LRP5-V667M", 
            "dbSNP IDs": [
                "rs4988321"
            ]
        }, 
        {
            "Allele Frequency": "0.0053", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "117267812", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Breathing", 
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "CFTR", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "11186891", 
                "15987793"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "4", 
                "Severity": "3", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported to cause mild dysfunction of the cystic fibrosis gene, it may result in cystic fibrosis when combined with more severe variants.", 
            "URL": "http://evidence.pgp-hms.org/CFTR-S1235R", 
            "Variant Name": "CFTR-S1235R", 
            "Variant Page": "http://evidence.pgp-hms.org/CFTR-S1235R", 
            "dbSNP IDs": [
                "rs34911792"
            ]
        }, 
        {
            "Allele Frequency": "0.04", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "124530664", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SIAE", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "20555325", 
                "22200769"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant was reported to be associated with autoimmune disease when homozygous. However, a later publication has contradicted this result, finding no significant association between this variant and autoimmune disease in a very large cohort.", 
            "URL": "http://evidence.pgp-hms.org/SIAE-M89V", 
            "Variant Name": "SIAE-M89V", 
            "Variant Page": "http://evidence.pgp-hms.org/SIAE-M89V", 
            "dbSNP IDs": [
                "rs78778622"
            ]
        }, 
        {
            "Allele Frequency": "0.012", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "42338993", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Blood"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SLC4A1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "8471774"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "-1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "5", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Rare and reported to cause hemolytic anemia in a recessive manner, although insufficient data is published to establish statistical significance. Polyphen 2 predicts a benign effect.", 
            "URL": "http://evidence.pgp-hms.org/SLC4A1-E40K", 
            "Variant Name": "SLC4A1-E40K", 
            "Variant Page": "http://evidence.pgp-hms.org/SLC4A1-E40K", 
            "dbSNP IDs": [
                "rs45562031"
            ]
        }, 
        {
            "Allele Frequency": "0.32", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "110818598", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Heart and circulatory"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "COL4A1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 3, 
            "PMID List": [
                "10334796", 
                "18077766", 
                "20031579"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.", 
            "URL": "http://evidence.pgp-hms.org/COL4A1-Q1334H", 
            "Variant Name": "COL4A1-Q1334H", 
            "Variant Page": "http://evidence.pgp-hms.org/COL4A1-Q1334H", 
            "dbSNP IDs": [
                "rs3742207"
            ]
        }, 
        {
            "Allele Frequency": "0.033", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "50745926", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Mouth, liver, and digestive"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "NOD2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 3, 
            "PMID List": [
                "11875755", 
                "12202985", 
                "12529700"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "NOD2 encodes a protein involved in bacterial recognition. This variant is associated with Crohn's disease in European populations, but not in Korean or Japanese groups.", 
            "URL": "http://evidence.pgp-hms.org/NOD2-R702W", 
            "Variant Name": "NOD2-R702W", 
            "Variant Page": "http://evidence.pgp-hms.org/NOD2-R702W", 
            "dbSNP IDs": [
                "rs2066844"
            ]
        }, 
        {
            "Allele Frequency": "0.039", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "57015091", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "CETP", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "17952847"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with slightly lower HDL (good) cholesterol, although it has a negligible effect (around 2 mg/dl).", 
            "URL": "http://evidence.pgp-hms.org/CETP-A390P", 
            "Variant Name": "CETP-A390P", 
            "Variant Page": "http://evidence.pgp-hms.org/CETP-A390P", 
            "dbSNP IDs": [
                "rs5880"
            ]
        }, 
        {
            "Allele Frequency": "0.45", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "7870973", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Anatomical and congenital", 
                "Metabolism", 
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "MTRR", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 7, 
            "PMID List": [
                "10444342", 
                "10930360", 
                "11807890", 
                "12375236", 
                "15060097", 
                "15979034", 
                "17024475"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "3", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as \"MTRR I22M\" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.", 
            "URL": "http://evidence.pgp-hms.org/MTRR-I49M", 
            "Variant Name": "MTRR-I49M", 
            "Variant Page": "http://evidence.pgp-hms.org/MTRR-I49M", 
            "dbSNP IDs": [
                "rs1801394"
            ]
        }, 
        {
            "Allele Frequency": "0.21", 
            "Build 37 Chromosome": "chr3", 
            "Build 37 Position": "148459988", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Drug response", 
                "Heart and circulatory"
            ], 
            "Evidence": "Likely", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "8021009", 
                "\n11250978", 
                "11593098", 
                "16046653", 
                "16675453", 
                "17668390"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": "2", 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.", 
            "URL": "http://evidence.pgp-hms.org/rs5186", 
            "Variant Name": "rs5186", 
            "Variant Page": "http://evidence.pgp-hms.org/rs5186", 
            "dbSNP IDs": [
                "rs5186"
            ]
        }, 
        {
            "Allele Frequency": "0.11", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "68201295", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Muscular, skeletal, and connective tissue"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "LRP5", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 3, 
            "PMID List": [
                "18455228", 
                "19148563", 
                "20953208"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "2", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "In a study of a UK population this variant was associated with a small increased risk of osteoporosis and osteoporotic bone fractures, with each copy of the variant presumed to have an additive effect. A study in Chinese young men failed to find an association with peak bone density.\n\n \n", 
            "URL": "http://evidence.pgp-hms.org/LRP5-A1330V", 
            "Variant Name": "LRP5-A1330V", 
            "Variant Page": "http://evidence.pgp-hms.org/LRP5-A1330V", 
            "dbSNP IDs": [
                "rs3736228"
            ]
        }, 
        {
            "Allele Frequency": "0.28", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "182554557", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer", 
                "Genital and urinary"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RNASEL", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "11941539", 
                "12022038", 
                "12415269", 
                "17407163"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.", 
            "URL": "http://evidence.pgp-hms.org/RNASEL-R462Q", 
            "Variant Name": "RNASEL-R462Q", 
            "Variant Page": "http://evidence.pgp-hms.org/RNASEL-R462Q", 
            "dbSNP IDs": [
                "rs486907"
            ]
        }, 
        {
            "Allele Frequency": "0.27", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "12915009", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer", 
                "Genital and urinary"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ELAC2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "12384782", 
                "15368467", 
                "18767027", 
                "20231859"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "2", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).", 
            "URL": "http://evidence.pgp-hms.org/ELAC2-S217L", 
            "Variant Name": "ELAC2-S217L", 
            "Variant Page": "http://evidence.pgp-hms.org/ELAC2-S217L", 
            "dbSNP IDs": [
                "rs4792311"
            ]
        }, 
        {
            "Allele Frequency": "0.14", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TGIF1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 1, 
            "PMID List": [
                "10556296"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.", 
            "URL": "http://evidence.pgp-hms.org/TGIF1-P83Shift", 
            "Variant Name": "TGIF1-P83Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/TGIF1-P83Shift", 
            "dbSNP IDs": [
                "rs11571510"
            ]
        }, 
        {
            "Allele Frequency": "0.24", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "32906729", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "BRCA2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "11062481", 
                "15235023"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.", 
            "URL": "http://evidence.pgp-hms.org/BRCA2-N372H", 
            "Variant Name": "BRCA2-N372H", 
            "Variant Page": "http://evidence.pgp-hms.org/BRCA2-N372H", 
            "dbSNP IDs": [
                "rs144848"
            ]
        }, 
        {
            "Allele Frequency": "0.63", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "7579472", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TP53", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "1975675", 
                "9607760", 
                "15355915", 
                "19837266", 
                "20615891", 
                "22184967"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.", 
            "URL": "http://evidence.pgp-hms.org/TP53-P72R", 
            "Variant Name": "TP53-P72R", 
            "Variant Page": "http://evidence.pgp-hms.org/TP53-P72R", 
            "dbSNP IDs": [
                "rs1042522"
            ]
        }, 
        {
            "Allele Frequency": "0.86", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "231050715", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SP110", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "16803959"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.", 
            "URL": "http://evidence.pgp-hms.org/SP110-L425S", 
            "Variant Name": "SP110-L425S", 
            "Variant Page": "http://evidence.pgp-hms.org/SP110-L425S", 
            "dbSNP IDs": [
                "rs3948464"
            ]
        }, 
        {
            "Allele Frequency": "0.097", 
            "Build 37 Chromosome": "chr10", 
            "Build 37 Position": "96702047", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Drug response", 
                "Metabolism"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "CYP2C9", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 7, 
            "PMID List": [
                "8004131", 
                "15947090", 
                "17161452", 
                "17686967", 
                "19228618", 
                "19794411", 
                "19794412"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "3", 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant, also called CYP2C9*2, is a pharmacogenetic variant that modulates sensitivity for Warfarin (due to reduced metabolism). This variant is associated with Caucasians. The FDA has approved reduced recommended Warfarin dosage based on the presence of this variant.", 
            "URL": "http://evidence.pgp-hms.org/CYP2C9-R144C", 
            "Variant Name": "CYP2C9-R144C", 
            "Variant Page": "http://evidence.pgp-hms.org/CYP2C9-R144C", 
            "dbSNP IDs": [
                "rs1799853"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": "-1", 
                "Penetrance": "0", 
                "Severity": "1", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ", 
            "URL": "http://evidence.pgp-hms.org/rs1544410", 
            "Variant Name": "rs1544410", 
            "Variant Page": "http://evidence.pgp-hms.org/rs1544410", 
            "dbSNP IDs": [
                "rs1544410"
            ]
        }, 
        {
            "Allele Frequency": "0.34", 
            "Build 37 Chromosome": "chr20", 
            "Build 37 Position": "4680251", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "PRNP", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 2, 
            "PMID List": [
                "18236005", 
                "19081515"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "0", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.\n\n", 
            "URL": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "Variant Name": "PRNP-M129V", 
            "Variant Page": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "dbSNP IDs": [
                "rs1799990"
            ]
        }, 
        {
            "Allele Frequency": "0.048", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "CCR5", 
            "Impact": "Protective", 
            "Inheritance": "Recessive", 
            "PMID Count": 3, 
            "PMID List": [
                "8751444", 
                "8791590", 
                "8898752"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Also known as CCR5-delta32, this variant is associated with resistance to many strains of HIV (but not all strains, only strains that use target the CCR5 protein). Heterozygotes are reported to have slower HIV progression, and homozygotes are very resistant to being infected by these strains.", 
            "URL": "http://evidence.pgp-hms.org/CCR5-S185Shift", 
            "Variant Name": "CCR5-S185Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/CCR5-S185Shift", 
            "dbSNP IDs": [
                "rs333"
            ]
        }, 
        {
            "Allele Frequency": "0.047", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "202074098", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "CASP10", 
            "Impact": "Protective", 
            "Inheritance": "Dominant", 
            "PMID Count": 2, 
            "PMID List": [
                "10412980", 
                "16251207"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported to have a protective effect on breast cancer. If the lifetime risk of breast cancer is 12%, women with this variant may have a lower risk of 8-9% (30% less than average).", 
            "URL": "http://evidence.pgp-hms.org/CASP10-V410I", 
            "Variant Name": "CASP10-V410I", 
            "Variant Page": "http://evidence.pgp-hms.org/CASP10-V410I", 
            "dbSNP IDs": [
                "rs13010627"
            ]
        }, 
        {
            "Allele Frequency": "0.39", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "196642233", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision", 
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "CFH", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 1, 
            "PMID List": [
                "15870199"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.", 
            "URL": "http://evidence.pgp-hms.org/CFH-V62I", 
            "Variant Name": "CFH-V62I", 
            "Variant Page": "http://evidence.pgp-hms.org/CFH-V62I", 
            "dbSNP IDs": [
                "rs800292"
            ]
        }, 
        {
            "Allele Frequency": "0.21", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "35874575", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system", 
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "IL7R", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 5, 
            "PMID List": [
                "12825072", 
                "17660530", 
                "17660816", 
                "17660817", 
                "21161391"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "-1", 
                "Familial": "0", 
                "Functional": "1", 
                "Penetrance": "0", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a \"protective\" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).", 
            "URL": "http://evidence.pgp-hms.org/IL7R-T244I", 
            "Variant Name": "IL7R-T244I", 
            "Variant Page": "http://evidence.pgp-hms.org/IL7R-T244I", 
            "dbSNP IDs": [
                "rs6897932"
            ]
        }, 
        {
            "Allele Frequency": "0.74", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "17409572", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "KCNJ11", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "17463246", 
                "17463248", 
                "20054294"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.", 
            "URL": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "Variant Name": "KCNJ11-K23E", 
            "Variant Page": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "dbSNP IDs": [
                "rs5219"
            ]
        }, 
        {
            "Allele Frequency": "0.068", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "44065090", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood", 
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "ABCG5", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19060911"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "2", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant has a mild protective effect on blood cholesterol. It is associated with slightly lower total and LDL cholesterol levels.", 
            "URL": "http://evidence.pgp-hms.org/ABCG5-R50C", 
            "Variant Name": "ABCG5-R50C", 
            "Variant Page": "http://evidence.pgp-hms.org/ABCG5-R50C", 
            "dbSNP IDs": [
                "rs6756629"
            ]
        }, 
        {
            "Allele Frequency": "0.22", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "237048500", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "MTR", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "10498402", 
                "14744749", 
                "17417062", 
                "17855192"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant was weakly associated with a protective effect vs. colorectal cancer, but only in individuals with low alcohol consumption.\n\n\n", 
            "URL": "http://evidence.pgp-hms.org/MTR-D919G", 
            "Variant Name": "MTR-D919G", 
            "Variant Page": "http://evidence.pgp-hms.org/MTR-D919G", 
            "dbSNP IDs": [
                "rs1805087"
            ]
        }, 
        {
            "Allele Frequency": "0.2", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "89017961", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "TYR", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 7, 
            "PMID List": [
                "1820207", 
                "7704033", 
                "11284711", 
                "18326704", 
                "18488027", 
                "18488028", 
                "19533789"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "0", 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.", 
            "URL": "http://evidence.pgp-hms.org/TYR-R402Q", 
            "Variant Name": "TYR-R402Q", 
            "Variant Page": "http://evidence.pgp-hms.org/TYR-R402Q", 
            "dbSNP IDs": [
                "rs1126809"
            ]
        }, 
        {
            "Allele Frequency": "0.051", 
            "Build 37 Chromosome": "chr15", 
            "Build 37 Position": "89803950", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "FANCI", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "17412408"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign.", 
            "URL": "http://evidence.pgp-hms.org/FANCI-P55L", 
            "Variant Name": "FANCI-P55L", 
            "Variant Page": "http://evidence.pgp-hms.org/FANCI-P55L", 
            "dbSNP IDs": [
                "rs62020347"
            ]
        }, 
        {
            "Allele Frequency": "0.068", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "238247734", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "COL6A3", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "9536084", 
                "15563506"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "1", 
                "Familial": "1", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign, reported by Pan et al. as a presumed-nonpathogenic variant in the gene.", 
            "URL": "http://evidence.pgp-hms.org/COL6A3-D2831H", 
            "Variant Name": "COL6A3-D2831H", 
            "Variant Page": "http://evidence.pgp-hms.org/COL6A3-D2831H", 
            "dbSNP IDs": [
                "rs36104025"
            ]
        }, 
        {
            "Allele Frequency": "0.016", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "1959699", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "GABRD", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "15115768", 
                "16023832"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "-1", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign, one report hypothesized this variant was associated with epilepsy, but a follow-up investigation failed to establish any statistically significant difference for this variant's incidence in control vs. affected populations.", 
            "URL": "http://evidence.pgp-hms.org/GABRD-R220H", 
            "Variant Name": "GABRD-R220H", 
            "Variant Page": "http://evidence.pgp-hms.org/GABRD-R220H", 
            "dbSNP IDs": [
                "rs41307846"
            ]
        }, 
        {
            "Allele Frequency": "0.044", 
            "Build 37 Chromosome": "chr6", 
            "Build 37 Position": "52303361", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "EFHC1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "7668263", 
                "15258581"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "Probably benign. OMIM appears to incorrectly interpret literature as linking this variant to juvenile myoclonic epilepsy; the authors report it as a polymorphism.", 
            "URL": "http://evidence.pgp-hms.org/EFHC1-R182H", 
            "Variant Name": "EFHC1-R182H", 
            "Variant Page": "http://evidence.pgp-hms.org/EFHC1-R182H", 
            "dbSNP IDs": [
                "rs3804505"
            ]
        }, 
        {
            "Allele Frequency": "0.23", 
            "Build 37 Chromosome": "chr14", 
            "Build 37 Position": "21790040", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RPGRIP1", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 2, 
            "PMID List": [
                "12920076", 
                "16272259"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "2", 
                "Familial": "-1", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.", 
            "URL": "http://evidence.pgp-hms.org/RPGRIP1-A547S", 
            "Variant Name": "RPGRIP1-A547S", 
            "Variant Page": "http://evidence.pgp-hms.org/RPGRIP1-A547S", 
            "dbSNP IDs": [
                "rs10151259"
            ]
        }, 
        {
            "Allele Frequency": "0.26", 
            "Build 37 Chromosome": "chr15", 
            "Build 37 Position": "74219546", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "LOXL1", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 3, 
            "PMID List": [
                "17690259", 
                "18450598", 
                "20142848"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.", 
            "URL": "http://evidence.pgp-hms.org/LOXL1-R141L", 
            "Variant Name": "LOXL1-R141L", 
            "Variant Page": "http://evidence.pgp-hms.org/LOXL1-R141L", 
            "dbSNP IDs": [
                "rs1048661"
            ]
        }, 
        {
            "Allele Frequency": "0.0032", 
            "Build 37 Chromosome": "chr18", 
            "Build 37 Position": "2929103", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood", 
                "Muscular, skeletal, and connective tissue", 
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "LPIN2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Unreported and rare, tentatively evaluated as benign. Other recessive mutations in this gene cause Majeed syndrome (multifocal osteomyelitis, anemia, and dermatosis). Although unstudied, LPIN2 is in a locus associated with psoriasis.", 
            "URL": "http://evidence.pgp-hms.org/LPIN2-L504F", 
            "Variant Name": "LPIN2-L504F", 
            "Variant Page": "http://evidence.pgp-hms.org/LPIN2-L504F", 
            "dbSNP IDs": [
                "rs104895500"
            ]
        }, 
        {
            "Allele Frequency": "0.07", 
            "Build 37 Chromosome": "chr10", 
            "Build 37 Position": "50678317", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ERCC6", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign.", 
            "URL": "http://evidence.pgp-hms.org/ERCC6-R1230P", 
            "Variant Name": "ERCC6-R1230P", 
            "Variant Page": "http://evidence.pgp-hms.org/ERCC6-R1230P", 
            "dbSNP IDs": [
                "rs4253211"
            ]
        }, 
        {
            "Allele Frequency": "1.0", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "21235475", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "APOB", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "5", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This position is almost certainly an error in the HG18 reference sequence. ", 
            "URL": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "Variant Name": "APOB-Y1422C", 
            "Variant Page": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "dbSNP IDs": [
                "rs568413"
            ]
        }, 
        {
            "Allele Frequency": "0.032", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "94512565", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ABCA4", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "9295268", 
                "11919200"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": "-1", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a polymorphism in a gene associated with Stargardt disease. Although it has a slight detectable effect in functional study, it is common in control groups and is not believed to have any significant pathogenic effect.", 
            "URL": "http://evidence.pgp-hms.org/ABCA4-R943Q", 
            "Variant Name": "ABCA4-R943Q", 
            "Variant Page": "http://evidence.pgp-hms.org/ABCA4-R943Q", 
            "dbSNP IDs": [
                "rs1801581"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build 37 Chromosome": "chr8", 
            "Build 37 Position": "55539395", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RP1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12764676", 
                "19364639"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.", 
            "URL": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "Variant Name": "RP1-N985Y", 
            "Variant Page": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "dbSNP IDs": [
                "rs2293869"
            ]
        }, 
        {
            "Allele Frequency": "0.0082", 
            "Build 37 Chromosome": "chr14", 
            "Build 37 Position": "75514489", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "MLH3", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "11586295", 
                "12702580", 
                "19156873"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "0", 
                "Familial": "1", 
                "Functional": "2", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign, follow-up studies have failed to support any link with colorectal cancer and the protein function is identical to wildtype.", 
            "URL": "http://evidence.pgp-hms.org/MLH3-E624Q", 
            "Variant Name": "MLH3-E624Q", 
            "Variant Page": "http://evidence.pgp-hms.org/MLH3-E624Q", 
            "dbSNP IDs": [
                "rs28756986"
            ]
        }, 
        {
            "Allele Frequency": "0.69", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "33951693", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SLC45A2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "15714523", 
                "17044855", 
                "18563784", 
                "18806926"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.", 
            "URL": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "Variant Name": "SLC45A2-L374F", 
            "Variant Page": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "dbSNP IDs": [
                "rs16891982"
            ]
        }, 
        {
            "Allele Frequency": "0.045", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "169483561", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "F5", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Other mutations in this gene are associated with Factor 5 deficiency. There is no literature implicating this variant, however, and it is fairly common in the population (3.8% in HapMap), and so it is currently labeled as benign.", 
            "URL": "http://evidence.pgp-hms.org/F5-D2222G", 
            "Variant Name": "F5-D2222G", 
            "Variant Page": "http://evidence.pgp-hms.org/F5-D2222G", 
            "dbSNP IDs": [
                "rs6027"
            ]
        }, 
        {
            "Allele Frequency": "0.89", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "55529187", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PCSK9", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19351729"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is likely benign. ", 
            "URL": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "Variant Name": "PCSK9-G670E", 
            "Variant Page": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "dbSNP IDs": [
                "rs505151"
            ]
        }, 
        {
            "Allele Frequency": "0.058", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "169521853", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "F5", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "17284699"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Presumed benign. This variant is not particularly rare and has not been reported to cause disease.", 
            "URL": "http://evidence.pgp-hms.org/F5-M413T", 
            "Variant Name": "F5-M413T", 
            "Variant Page": "http://evidence.pgp-hms.org/F5-M413T", 
            "dbSNP IDs": [
                "rs6033"
            ]
        }
    ]
}